In a report to be released Tuesday, the Global Commission on Drug Policy , a panel of prominent political figures and activists, will call upon governments around the world to decriminalize drug use and legalize marijuana. Members of the commission, including former Secretary General of the United Nations Kofi Annan, former Mexican President Ernesto Zedillo, former U.S. Federal Reserve Chair Paul Volcker...
A meteorite that landed near the Nicaraguan capital Managua on Sunday could have come from the 2014 RC asteroid which was passing the earth at the time, experts have said....
Scientists are exploring why it is so difficult at accurately measure the Newtonian constant of gravity....
Archaeologists date the weapon to the Shang or Zhou dynasties - the dawn of Chinese civilisation....
A small meteorite which may have broken off an asteroid caused a 12m-wide crater near Managua's international airport, Nicaraguan officials say....
Ebola is spreading exponentially in Liberia, with many thousands of new cases expected in next three weeks, the World Health Organization says....
Scientists from the University of Birmingham compile a database that identifies and maps the wild relatives of common food crops....
Concentrations of warming gases in the atmosphere reached record levels in 2013 say the World Meteorological Organisation....
A new study reports researchers have been successful in harnessing a mouse's immune system to attack and remove the buildup of toxic proteins in the brain which are markers for Alzheimer's. ...
The stiffness of the surface on which stem cells grow can have a profound influence on the cell fate, a new study reports. ...
Researchers discover the IP3R receptor can be locked into closed state by enzyme action. This could potentially play a role in the reduction of neuron signaling seen in some neurodegenerative disorders. ...
Researchers report they have uncovered a new treatment for perinatal brain injuries. ...
When Hurricane Katrina bore down on New Orleans in August of 2005, federal officials couldn't predict how it would behave with any real certainty until two days before landfall. Next time, their fortune-telling is likely to be far more accurate, thanks to a new type of hurricane-proof data-gathering drone now in development. Current hurricane-hunting planes gather data on winds, pressure, precipitation...
Greetings from Norway's spectacular Lofoten Islands, one of the crown jewels of our planet's biodiversity: an environment above the Arctic Circle where coral reefs actually thrive, seabirds by the millions roost, and Orcas, humpbacks, and sperm wales — not to mention humans — feast on teeming stocks of fish. This biodiversity has been described as an Arctic Amazon rainforest and Great Barrier Reef...
AstraZeneca was forced to concede a clinical defeat on Monday, noting that one of its top respiratory drugs in the clinic failed a study for severe chronic obstructive pulmonary disease. But while investigators also flagged a higher rate of adverse events for benralizumab than the placebo arm, the pharma giant shows no signs of backing away from a treatment it's billed as a potential $2 billion...
When the FDA came through with their expected approval for Keryx's ferric citrate (formerly Zerenex), a new treatment to deal with complications of kidney disease, on Friday, a label warning that the drug could wind up triggering iron overload dampened analysts' enthusiasm for this treatment considerably, with Keryx's stock price ending Friday down 5%. ...
Back last April when Brisbane, CA-based Hyperion agreed to pay $20 million in cash and stock for Israel's Andromeda Biotech, while promising $550 million more in milestones, company execs made much of the late-stage data already in hand for a new Type 1 diabetes drug. Today, though, Hyperion's team threw up their hands and surrendered, claiming that they had been duped by a group of Andromeda staffers...
Investigators for GlaxoSmithKline detailed their promising Phase III data for the IL-5 biologic mepolizumab in asthma today, noting that the injectable halved the rate of exacerbations among a group of patients with uncontrolled cases of the respiratory disease. But while the pharma giant was making its case for a lower dosage of the drug for a particular profile of asthma patient, an expert in the...
Ophthotech says it won a $50 million enrollment milestone from Novartis for reaching a goal on its Phase III Fovista study for wet, age-related macular degeneration....
GlaxoSmithKline is looking to set some drug development records as it races to the clinic with an Ebola vaccine, posting promising results in preclinical study as a public health crisis unfolds in Africa. ...